UY30030A1 - Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones - Google Patents

Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones

Info

Publication number
UY30030A1
UY30030A1 UY30030A UY30030A UY30030A1 UY 30030 A1 UY30030 A1 UY 30030A1 UY 30030 A UY30030 A UY 30030A UY 30030 A UY30030 A UY 30030A UY 30030 A1 UY30030 A1 UY 30030A1
Authority
UY
Uruguay
Prior art keywords
piracin
espiro
tetrahidro
pirimidin
oxacin
Prior art date
Application number
UY30030A
Other languages
English (en)
Spanish (es)
Inventor
Peter Laurence Toogood
Dennis Joseph Mcnamara
Debra Ann Sherry
Timothy Allen Johnson
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37872452&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30030(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of UY30030A1 publication Critical patent/UY30030A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
UY30030A 2005-12-22 2006-12-19 Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones UY30030A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US75326205P 2005-12-22 2005-12-22

Publications (1)

Publication Number Publication Date
UY30030A1 true UY30030A1 (es) 2007-07-31

Family

ID=37872452

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30030A UY30030A1 (es) 2005-12-22 2006-12-19 Derivados sustituidos de la 8-piracin-2-il-1,2,4,4a-tetrahidro-2´h, 6h-espiro (1,4-oxacin(4,3-a)quinolin-5,5´-pirimidin)-2´, 4´, 6´ (1´h, 3´h)-tiona, composiciones y aplicaciones

Country Status (12)

Country Link
US (2) US7557100B2 (enExample)
EP (2) EP2620439A1 (enExample)
JP (1) JP5513743B2 (enExample)
AR (1) AR058701A1 (enExample)
CA (1) CA2634644A1 (enExample)
DO (1) DOP2006000268A (enExample)
GT (1) GT200600520A (enExample)
NL (1) NL2000373C2 (enExample)
PE (1) PE20071137A1 (enExample)
TW (1) TW200734344A (enExample)
UY (1) UY30030A1 (enExample)
WO (1) WO2007072151A1 (enExample)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos
RU2010103101A (ru) * 2007-07-02 2011-08-10 Астразенека Аб (Se) Химические соединения
ATE523592T1 (de) * 2007-07-06 2011-09-15 Univ Aarhus Dehydratisierte chitosan-nanopartikel
US20110178064A1 (en) 2007-07-16 2011-07-21 Astrazeneca R&D Spiro condensed barbituric acid derivatives for use as antibacterial
AU2008316830B2 (en) 2007-10-25 2016-03-17 Cempra Pharmaceuticals, Inc. Process for the preparation of macrolide antibacterial agents
US9040528B2 (en) 2008-10-14 2015-05-26 Astrazeneca Ab Chemical compounds 542
TW201020258A (en) * 2008-10-14 2010-06-01 Astrazeneca Ab Chemical compounds 542
CN107854477A (zh) 2008-10-24 2018-03-30 森普拉制药公司 使用含三唑的大环内酯治疗抗性疾病的方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
US9480679B2 (en) 2009-09-10 2016-11-01 Cempra Pharmaceuticals, Inc. Methods for treating malaria, tuberculosis and MAC diseases
HRP20160168T1 (hr) 2010-03-22 2016-03-25 Cempra Pharmaceuticals Inc Kristalne forme makrolida i njihova uporaba
BR112012029586A2 (pt) 2010-05-20 2016-08-02 Cempra Pharmaceuticals Inc processos para preparar macrolídeos e cetolídeos e intermediários dos mesmos
KR20130120458A (ko) 2010-09-10 2013-11-04 셈프라 파마슈티컬스, 인크. 질환을 치료하기 위한 수소결합 형성 플루오로 케토라이드
WO2013148891A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
US8952149B2 (en) 2012-09-26 2015-02-10 Zoetis Llc Tricyclic tetrahydroquinoline antibacterial agents
US8889671B2 (en) 2013-01-23 2014-11-18 Astrazeneca Ab Compounds and methods for treating bacterial infections
WO2014152326A1 (en) 2013-03-14 2014-09-25 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
AU2014233240B2 (en) 2013-03-15 2018-08-09 Cempra Pharmaceuticals, Inc. Convergent processes for preparing macrolide antibacterial agents
SG11201609404SA (en) 2014-05-29 2016-12-29 Entasis Therapeutics Ltd Fused, spirocyclic heteroaromatic compounds for the treatment of bacterial infections
UY36851A (es) 2015-08-16 2017-03-31 Glaxosmithkline Ip Dev Ltd Compuestos para uso en aplicaciones antibacterianas
IL317854A (en) 2017-07-28 2025-02-01 Takeda Pharmaceuticals Co TYK2 inhibitors and their uses

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5011860A (en) * 1986-04-11 1991-04-30 Schering Corporation Aryl-substituted naphthyridine and pyridopyrazine derivatives and their use in treating hyperproliferative skin diseases
DE19502178A1 (de) * 1994-01-27 1995-08-03 Hoechst Ag Thiadiazolderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Vorprodukte zur Herstellung von Flüssigkristallen
US6608081B2 (en) * 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
CZ20031083A3 (cs) 2000-10-26 2004-03-17 Pfizer Products Inc. 5-Spiropyrimidin-2, 4, 6-trionové inhibitory metaloproteinasy
BR0210099A (pt) * 2001-05-30 2004-04-13 Warner Lambert Co Agentes antibacterianos
AU2003228701A1 (en) 2002-04-25 2003-11-10 Bristol-Myers Squibb Company Spirobarbituric acid derivatives useful as inhibitors of matrix metalloproteases
US7208490B2 (en) 2002-10-07 2007-04-24 Pharmacia & Upjohn Company Llc Tricyclic tetrahydroquinoline antibacterial agents
CA2606847A1 (en) 2005-05-09 2006-11-16 Warner-Lambert Company Llc Antibacterial agents
DOP2006000268A (es) * 2005-12-22 2007-07-31 Pfizer Prod Inc Agentes antibacterianos

Also Published As

Publication number Publication date
WO2007072151A1 (en) 2007-06-28
JP5513743B2 (ja) 2014-06-04
JP2009520804A (ja) 2009-05-28
US20090275536A1 (en) 2009-11-05
NL2000373A1 (nl) 2007-06-26
AR058701A1 (es) 2008-02-20
TW200734344A (en) 2007-09-16
CA2634644A1 (en) 2007-06-28
US7557100B2 (en) 2009-07-07
NL2000373C2 (nl) 2010-02-02
US20070197518A1 (en) 2007-08-23
GT200600520A (es) 2007-07-17
EP1971612A1 (en) 2008-09-24
EP2620439A1 (en) 2013-07-31
PE20071137A1 (es) 2008-01-10
DOP2006000268A (es) 2007-07-31

Similar Documents

Publication Publication Date Title
DOP2006000268A (es) Agentes antibacterianos
ECSP099451A (es) Compuestos de urea policíclicos antibacterianos
ATE433447T1 (de) Pyrimiidinverbindungen
BRPI0809977A8 (pt) Uso de um composto, compostos e composição farmacêutica que o contém
UY32158A (es) Derivados heterociclicos y metodos de uso de los mismos
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
CY1110813T1 (el) Χημικες ενωσεις
CY1109916T1 (el) Βενζιμιδαζολο-θειοφαινικες ενωσεις ως plk αναστολεις
UY28510A1 (es) Compuestos quimicos
BRPI0813450B8 (pt) composto, formulação farmacêutica, e, usos do composto
UY29795A1 (es) Derivados de adenina, composiciones farmacéuticas que los contienen, procesos de preparación y aplicaciones
ATE365740T1 (de) Substituierte pyrazolopyrimidine
GT200400146A (es) Derivados sustituidos del dioxido de tiazol-benzoisotiazol, procedimiento para su preparacion y su uso
UY30544A1 (es) Compuestos de pirrolo-piperidina y sales farmacéuticametne aceptables de los mismos, procesos de fabricacion, composiciones y aplicaciones
AR029226A1 (es) Tioamidas, composiciones farmaceuticas y el uso de la misma para la fabricacion de compuestos medicinales
DK1641803T3 (da) Thienopyrimidinderivater som kaliumkanalinhibitorer
CY1112960T1 (el) Παραγωγα ουριας, μεθοδοι για την παρασκευη τους και χρησεις αυτων
EA200600280A1 (ru) Композиции на основе производных липопептидных антибиотиков и способы их применения
BRPI0408817A (pt) composto, processo de preparação do mesmo, composição farmacêutico, e, utilização de um composto
BRPI0413151A (pt) derivados de amino propanol
UY29767A1 (es) Derivados de benzotiazolonas, procesos para su preparación, composiciones farmacéuticas que los contienen y aplicaciones
UY29732A1 (es) Derivados de benzotiazolonas, procesos de preparación, composiciones y combinaciones que los contienen y aplicaciones
CO2019010001A2 (es) Antibióticos macrociclicos de amplio espectro
CL2004000979A1 (es) Nonapeptidos acilados tipo lysobacitina, composicion que los contiene metodo de preparacion, util como bactericida.
CR7956A (es) Oxazolidinonas de indolona antibacterial intermedios para su preparacion y composiciones farmaceuticas que contienen los mismos

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20161205